The Curative Effect and Security of Interferon Combined Resveratrol on HBeAg Positive Chronic Hepatitis B Patients
Status:
Completed
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to use Interferon Combined Resveratrol to treat patients with
hepatitis B, which may provide a novel therapy target hepatitis B.
Phase:
N/A
Details
Lead Sponsor:
First Hospital of Jilin University The First Hospital of Jilin University